ProMIS Neurosciences Inc
TSX:PMN
ProMIS Neurosciences Inc
TSX:PMN
Price:
6
CAD
-3.85%
Market Closed
Market Cap:
CA$51.5m
Balance Sheet
Balance Sheet Decomposition
ProMIS Neurosciences Inc
ProMIS Neurosciences Inc
Balance Sheet Decomposition is not available for
ProMIS Neurosciences Inc
ProMIS Neurosciences Inc
Balance Sheet
ProMIS Neurosciences Inc
ProMIS Neurosciences Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
2
|
2
|
2
|
1
|
17
|
6
|
|
| Cash Equivalents |
0
|
1
|
1
|
2
|
2
|
2
|
1
|
17
|
6
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
0
|
1
|
1
|
2
|
3
|
2
|
1
|
18
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+297%
|
1
-16%
|
2
+124%
|
3
+37%
|
2
-30%
|
1
-33%
|
18
+1 186%
|
7
-61%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
2
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
2
|
|
| Total Liabilities |
0
N/A
|
1
+12%
|
1
+64%
|
1
-29%
|
2
+183%
|
2
-7%
|
2
+43%
|
12
+404%
|
8
-32%
|
|
| Equity | ||||||||||
| Common Stock |
28
|
30
|
33
|
37
|
45
|
49
|
53
|
0
|
0
|
|
| Retained Earnings |
36
|
39
|
42
|
48
|
58
|
66
|
71
|
62
|
0
|
|
| Additional Paid In Capital |
5
|
7
|
8
|
8
|
8
|
8
|
8
|
68
|
79
|
|
| Other Equity |
3
|
1
|
1
|
4
|
6
|
9
|
9
|
0
|
80
|
|
| Total Equity |
0
N/A
|
1
N/A
|
0
-88%
|
2
+2 086%
|
1
-24%
|
0
-66%
|
1
N/A
|
6
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+297%
|
1
-16%
|
2
+124%
|
3
+37%
|
2
-30%
|
1
-33%
|
18
+1 186%
|
7
-61%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
69
|
154
|
182
|
220
|
247
|
275
|
290
|
7
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
